Bendell, J. C., Montagut Viladot, C., Hurwitz, H., & Group, M. S. (2020). The McCAVE Trial: Vanucizumab plus mFOLFOX-6 versus bevacizumab plus mFOLFOX-6 in patients with previously untreated metastatic colorectal carcinoma (mCRC). Wiley.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Bendell, Johanna C., Clara Montagut Viladot, Herbert Hurwitz, y McCAVE Study Group. The McCAVE Trial: Vanucizumab Plus MFOLFOX-6 Versus Bevacizumab Plus MFOLFOX-6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC). Wiley, 2020.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Bendell, Johanna C., et al. The McCAVE Trial: Vanucizumab Plus MFOLFOX-6 Versus Bevacizumab Plus MFOLFOX-6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC). Wiley, 2020.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.